Publicaciones en las que colabora con Esperanza Pato Cour (8)

2022

  1. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

2015

  1. Study of association of CTLA4 gene variants to non-anterior uveitis

    Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376

2014

  1. AB0571 High Dose Intravenous Methylprednisolone Induces RAPID Improvement in Severe Ocular Inflammation. Multicenter Study of 104 Cases

    Annals of the Rheumatic Diseases, Vol. 73, Núm. Suppl 2, pp. 995.1-995

  2. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients

    Rheumatology (Oxford, England), Vol. 53, Núm. 12, pp. 2223-2231

2013

  1. No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis

    PLoS ONE, Vol. 8, Núm. 11

  2. Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis

    PLoS ONE, Vol. 8, Núm. 10